Cognitive Decline Is Associated with Systemic Oxidative Stress: The EVA Study

OBJECTIVE: To determine whether systemic oxidative stress status is associated with cognitive decline.

[1]  H. Stähelin,et al.  The Relation Between Antioxidants and Memory Performance in the Old and Very Old , 1997, Journal of the American Geriatrics Society.

[2]  W. Pryor,et al.  Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. , 1998, Free radical biology & medicine.

[3]  A. Hofman,et al.  Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. , 1996, American journal of epidemiology.

[4]  M. Beal,et al.  Aging, energy, and oxidative stress in neurodegenerative diseases , 1995, Annals of neurology.

[5]  P. Amouyel,et al.  Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel. , 1996, Neuroscience letters.

[6]  R. Cumming,et al.  Cohort study of vitamin C intake and cognitive impairment. , 1998, American journal of epidemiology.

[7]  B. Ames,et al.  The free radical theory of aging matures. , 1998, Physiological reviews.

[8]  W. Stahl,et al.  Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. , 1995, The American journal of clinical nutrition.

[9]  L. Launer,et al.  Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies. , 1998, Journal of neural transmission. Supplementum.

[10]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Goodwin,et al.  Association between nutritional status and cognitive functioning in a healthy elderly population. , 1983, JAMA.

[12]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[13]  G. Multhaup.  Amyloid precursor protein, copper and Alzheimer's disease. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  J. Arnaud,et al.  Selenium determination in human milk in Niger: influence of maternal status. , 1993, Journal of trace elements and electrolytes in health and disease.

[15]  C. Berr,et al.  Systemic oxidative stress and cognitive performance in the population-based EVA study. Etude du Vieillissement Artériel. , 1998, Free radical biology & medicine.

[16]  E. Feskens,et al.  Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. , 1997, American journal of epidemiology.

[17]  L. Klotz,et al.  Glutathione Peroxidase Protects against Peroxynitrite-mediated Oxidations , 1997, The Journal of Biological Chemistry.

[18]  A. Alpérovitch,et al.  Demographic and cardiovascular risk factors in relation to antioxidant status: the EVA Study. , 1998, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[19]  S. Bondy,et al.  Reactive oxygen species: relation to aging and neurotoxic damage. , 1992, Neurotoxicology.

[20]  M. Kendall,et al.  The oxidation hypothesis of atherosclerosis , 1994, The Lancet.

[21]  M. Ganguli,et al.  Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey. , 1998, American journal of epidemiology.

[22]  B. Halliwell,et al.  Lipid peroxidation: its mechanism, measurement, and significance. , 1993, The American journal of clinical nutrition.

[23]  D M Tucker,et al.  Nutrition status and brain function in aging. , 1990, The American journal of clinical nutrition.

[24]  B. Halliwell,et al.  Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? , 1994, The Lancet.

[25]  A. Folsom,et al.  Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. , 1996, The New England journal of medicine.

[26]  C. Martyn,et al.  Cognitive impairment and mortality in a cohort of elderly people , 1996, BMJ.

[27]  A. Favier,et al.  Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. , 1992, Clinical chemistry.

[28]  R. Schmidt,et al.  Plasma Antioxidants and Cognitive Performance in Middle‐Aged and Older Adults: Results of the Austrian Stroke Prevention Study , 1998, Journal of the American Geriatrics Society.

[29]  P. Touboul,et al.  Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Artériel. , 1997, The American journal of clinical nutrition.

[30]  D. Harman.  Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.

[31]  K. Haaland,et al.  Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. , 1997, The American journal of clinical nutrition.

[32]  P Woodbury,et al.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.

[33]  M. Karagas,et al.  Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. , 1997, JAMA.

[34]  P. Amouyel,et al.  Early effect of ApoE-ϵ4 allele on cognitive results in a group of highly performing subjects: the EVA study , 1996, Neuroscience Letters.

[35]  E. D. Harris,et al.  Regulation of antioxidant enzymes. , 1992, The Journal of nutrition.

[36]  F. Kelly,et al.  Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) , 1996, The Lancet.